Professor Philip Shapira's research was quoted in an article from Science about how new research on Covid-19 is beginning to decrease.

An excerpt:

"The easing of the COVID-19 publishing frenzy doesn’t diminish the value of the work done by scientists who jumped into COVID-19 research—and of the experience they gained. 'Not everything paid off,' Shapira says. But the influx 'probably trained a whole set of researchers to think about pandemics from medical, public health, and other aspects. There’s been a human capital investment.'”